Results 1 to 10 of about 68,105 (186)

Colistin Does Not Potentiate Ceftazidime-Avibactam Killing of Carbapenem-Resistant Enterobacteriaceae in Vitro or Suppress Emergence of Ceftazidime-Avibactam Resistance.

open access: yesAntimicrobial Agents and Chemotherapy, 2018
We tested ceftazidime-avibactam and colistin against 24 carbapenem-resistant Enterobacteriaceae (CRE) isolates by time-kill studies. Ceftazidime-avibactam at 0.25×, 1×, and 4× the MIC was bactericidal against 8%, 21%,
Hung T. Nguyen   +2 more
exaly   +2 more sources
Some of the next articles are maybe not open access.

Ceftazidime and Salmonella.

Lancet, The, 1982
Wolfgang Stille, Pravin M Shāh
exaly  

Ceftazidime Monotherapy for Empiric Treatment of Febrile Neutropenic Patients: A Meta-Analysis.

Journal of Infectious Diseases, 1991
Richard Moore   +2 more
exaly  

Ecological Effect of Ceftazidime/Avibactam on the Normal Human Intestinal Microbiota

International Journal of Antimicrobial Agents, 2015
Staffan Rosenborg   +2 more
exaly  

In‐Vitro Activity of Ceftazidime‐Avibactam and Comparator Agents Against Carbapenem‐Resistant Gram‐Negative Isolates at a Tertiary Care Hospital in Lahore, Pakistan: A Cross‐Sectional Study [PDF]

open access: yesMicrobiologyOpen, Volume 15, Issue 6, December 2026.
Of 210 consecutive non‐duplicate carbapenem‐resistant Gram‐negative isolates collected at a tertiary care hospital in Lahore, Pakistan (December 2024–May 2025), 200 had a ceftazidime‐avibactam (CAZ–AVI) result; 70.5% were susceptible (141/200; 95% CI 63.7–76.7). Susceptibility varied by sample source (p = 0.008), being highest in blood cultures (81.2%),
Faryal Yunus   +5 more
wiley   +2 more sources

Home - About - Disclaimer - Privacy